Author:
Moraes Fabio Y.,Mendez Lucas C.,Taunk Neil K.,Raman Srinivas,Suh John H.,Souhami Luis,Slotman Ben,Weltman Eduardo,Spratt Daniel E.,Berlin Alejandro,Marta Gustavo N.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Neurology,Neurology,Oncology
Reference33 articles.
1. Chakravarthy R et Al. Public and Private Sector Contributions to the Research & Development of the Most Transformational Drugs of the Last 25 Years.
http://csdd.tufts.edu/files/uploads/PubPrivPaper2015.pdf
. Boston, Mass.: Tufts Center for the Study of Drug Development; January 2015
2. Pharmaceutical Research and Manufacturers of America (PhRMA) (2015) PhRMA Annual Membership Survey. PhRMA, Washington, DC
3. National Institutes of Health (NIH), Office of Budget (2016) Budget Roll Out.
http://www.nih.gov/about/director/budgetrequest/fy2016_directorsbudgetrequest_slides.pdf
. Bethesda, Md.: NIH; 2015. Accessed March 2015
4. Ehrhardt S, Appel LJ, Meinert CL (2015) Trends in National Institutes of Health Funding for Clinical Trials Registered in ClinicalTrials.gov. JAMA 314(23):2566–2567.
https://doi.org/10.1001/jama.2015.12206
5. Valachis A, Polyzos NP, Nearchou A, Lind P, Mauri D (2012) Financial relationships in economic analyses of targeted therapies in oncology. J Clin Oncol Off J Am Soc Clin Oncol 30(12):1316–1320.
https://doi.org/10.1200/JCO.2011.38.6078
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献